1 Min Read
March 9 (Reuters) - Aurinia Pharmaceuticals Inc:
* Aurinia reports fourth quarter and full year 2016 financial results and recent operational highlights
* Q4 loss per share $0.21 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.